Shanghai Longwood Biopharmaceuticals Co., Ltd.

This study is testing whether an oral medication called LW402 can safely reduce the symptoms of moderate-to-severe eczema (atopic dermatitis). Approximately 480 adult participants with significant eczema will take either the active pill or a placebo for 16 weeks. Researchers will…